Search Results
10
Everything
Search Filters
Tag
Biotechnology
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
November 12, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
November 12, 2024 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in a fireside chat at the 2024...
Hyku Biosciences Appoints John Gustofson to its Board of Directors
November 12, 2024 07:45 ET
|
Hyku Biosciences
John Gustofson, MS, MBA appointed to the Board of Directors The appointment is in conjunction with Chugai Venture Fund joining syndicate with an investment that brings Hyku’s total seed financing to...
TransCode Therapeutics Open Letter to Shareholders
November 12, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
Open Letter to Shareholders
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
November 12, 2024 05:30 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
November 11, 2024 07:30 ET
|
Cytokinetics, Incorporated
Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated...
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
November 11, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
Orphan Drug Designation has been granted lately by US FDA RAMAT GAN, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
Ocugen Provides Business Update with Third Quarter 2024 Financial Results
November 08, 2024 06:45 ET
|
Ocugen
Subsequent to quarter-end, closed $30 million in debt financingOCU400 Phase 3 liMeliGhT clinical trial for retinitis pigmentosa (RP) on track to complete enrollment in 1H2025OCU410 is currently in...
FDA Regulatory Compliance for Drug and Biotech Product Training Course (ONLINE EVENT: December 2-3, 2024/ON-DEMAND)
November 08, 2024 05:05 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course...
Technical Writing Course for the Pharmaceutical, Medical Device and Biotech Industries (ONLINE EVENT: December 2-4, 2024/ON-DEMAND)
November 08, 2024 04:54 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Technical Writing for the Pharmaceutical, Medical Device and Biotech Industries" training has been added to ResearchAndMarkets.com's offering. This...